Literature DB >> 18593772

Perspectives for improved and more accurate classification of thyroid epithelial tumors.

Markus Eszlinger1, Knut Krohn, Steffen Hauptmann, Henning Dralle, Thomas J Giordano, Ralf Paschke.   

Abstract

CONTEXT: Histologic examination of thyroid nodules is the current standard to distinguish benign from malignant thyroid epithelial tumors and to classify histologic subtypes. This review analyzes the problems in histological differential diagnosis as well as contradictions between histology and molecular data and describes possibilities to combine histology with molecular data in an effort to more accurately classify thyroid epithelial tumors. EVIDENCE ACQUISITION: Published literature, addressing the current recommendations for thyroid tumor classification, as well as literature on the application of histology and molecular studies on the etiology of thyroid tumors is analyzed. EVIDENCE SYNTHESIS: The current histologic criteria to classify thyroid tumors, especially follicular-patterned tumors, are hampered by considerable interobserver variability. The detection of somatic mutations via genotyping and the definition of potentially informative gene expression signatures by microarray analyses, which can distinguish cancer subtypes as well as low- and high-risk cohorts, have recently demonstrated significant diagnostic potential. Moreover, in a routine diagnostic setting, micro-RNA profiling appears most promising due to their relative stability and the high accuracy of their expression profiles.
CONCLUSIONS: It is very likely that molecular definitions of thyroid tumors mentioned in the current World Health Organization classification will be further developed, leading to future progress in defining thyroid tumor types by an integrated histologic and molecular approach. These integrated classifications need to be evaluated for their specific impact on thyroid tumor diagnosis and prognosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18593772     DOI: 10.1210/jc.2008-0201

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

Review 1.  Non-malignant thyroid diseases after a wide range of radiation exposures.

Authors:  Elaine Ron; Alina Brenner
Journal:  Radiat Res       Date:  2010-09-07       Impact factor: 2.841

2.  Telomere length is related to alternative splice patterns of telomerase in thyroid tumors.

Authors:  Yongchun Wang; Alan K Meeker; Jeanne Kowalski; Hua-Ling Tsai; Helina Somervell; Christopher Heaphy; Lauren E Sangenario; Nijaguna Prasad; William H Westra; Martha A Zeiger; Christopher B Umbricht
Journal:  Am J Pathol       Date:  2011-07-16       Impact factor: 4.307

Review 3.  Thyroid nodule guidelines: agreement, disagreement and need for future research.

Authors:  Ralf Paschke; Laszlo Hegedüs; Erik Alexander; Roberto Valcavi; Enrico Papini; Hossein Gharib
Journal:  Nat Rev Endocrinol       Date:  2011-03-01       Impact factor: 43.330

Review 4.  Prognostic biomarkers in thyroid cancer.

Authors:  Paula Soares; Ricardo Celestino; Miguel Melo; Elsa Fonseca; Manuel Sobrinho-Simões
Journal:  Virchows Arch       Date:  2014-02-01       Impact factor: 4.064

5.  Evaluation of the PAX8/PPARG translocation in follicular thyroid cancer with a 4-color reverse-transcription PCR assay and automated high-resolution fragment analysis.

Authors:  Alicia Algeciras-Schimnich; Dragana Milosevic; Bryan McIver; Heather Flynn; Honey V Reddi; Norman L Eberhardt; Stefan K G Grebe
Journal:  Clin Chem       Date:  2010-01-07       Impact factor: 8.327

6.  Molecular differences between human thyroid follicular adenoma and carcinoma revealed by analysis of a murine model of thyroid cancer.

Authors:  Marialuisa Sponziello; Elisa Lavarone; Enrico Pegolo; Carla Di Loreto; Cinzia Puppin; Marika A Russo; Rocco Bruno; Sebastiano Filetti; Cosimo Durante; Diego Russo; Antonio Di Cristofano; Giuseppe Damante
Journal:  Endocrinology       Date:  2013-06-10       Impact factor: 4.736

7.  Rap2A Is Upregulated in Invasive Cells Dissected from Follicular Thyroid Cancer.

Authors:  Indira Prabakaran; Jillian R Grau; Robert Lewis; Douglas L Fraker; Marina A Guvakova
Journal:  J Thyroid Res       Date:  2011-10-20

8.  Increasing the number of thyroid lesions classes in microarray analysis improves the relevance of diagnostic markers.

Authors:  Jean-Fred Fontaine; Delphine Mirebeau-Prunier; Mahatsangy Raharijaona; Brigitte Franc; Stephane Triau; Patrice Rodien; Olivier Goëau-Brissonniére; Lucie Karayan-Tapon; Marielle Mello; Rémi Houlgatte; Yves Malthiery; Frédérique Savagner
Journal:  PLoS One       Date:  2009-10-29       Impact factor: 3.240

9.  Differential expression profiling and functional analysis of microRNAs through stage I-III papillary thyroid carcinoma.

Authors:  Jing Zhang; Yang Liu; Zheng Liu; Xiao-Ming Wang; De-Tao Yin; Li-Li Zheng; De-Yan Zhang; Xiu-Bo Lu
Journal:  Int J Med Sci       Date:  2013-03-16       Impact factor: 3.738

Review 10.  Bridging the clinical gaps: genetic, epigenetic and transcriptomic biomarkers for the early detection of lung cancer in the post-National Lung Screening Trial era.

Authors:  John F Brothers; Kahkeshan Hijazi; Celine Mascaux; Randa A El-Zein; Margaret R Spitz; Avrum Spira
Journal:  BMC Med       Date:  2013-07-19       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.